Current Vascular Pharmacology
Title:Meet Our Editorial Board Member
Volume: 16 Issue: 3
Author(s): Aurelio Leone
Affiliation:
Export Options
About this article
Cite this article as:
Leone Aurelio , Meet Our Editorial Board Member, Current Vascular Pharmacology 2018; 16 (3) . https://dx.doi.org/10.2174/157016111603180326112112
DOI https://dx.doi.org/10.2174/157016111603180326112112 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Current Role of Statin Therapy in the Treatment of Atrial Fibrillation
Cardiovascular & Hematological Agents in Medicinal Chemistry It’s Time for An Epigenomics Roadmap of Heart Failure
Current Genomics Genetic Imbalance in Patients with Cervical Artery Dissection
Current Genomics Complications of Infective Endocarditis
Cardiovascular & Hematological Disorders-Drug Targets Myocardial Infarction Following Atherosclerosis in Murine Models
Current Drug Targets A Comparative Summary on Antioxidant-like Actions of Timolol with Other Antioxidants in Diabetic Cardiomyopathy
Current Drug Delivery Cerebrospinal Fluid Flow Dynamics in Multiple Sclerosis Patients through Phase Contrast Magnetic Resonance Imaging
Current Neurovascular Research Lipid Nanoparticles as Vehicles for Macromolecules: Nucleic Acids and Peptides
Recent Patents on Drug Delivery & Formulation Oxidative and Non-Oxidative Metabolomics of Ethanol
Current Drug Metabolism Current Approaches to Prevention of Contrast Induced Acute Kidney Injury
Cardiovascular & Hematological Agents in Medicinal Chemistry Red Blood Cell Indices in Relation to Post-stroke Psychiatric Disorders: A Longitudinal Study in a Follow-up Stroke Clinic
Current Neurovascular Research Heme Oxygenase-1: Clinical Relevance in Ischemic Stroke
Current Pharmaceutical Design Nitric Oxide, Malnutrition and Chronic Renal Failure
Cardiovascular & Hematological Agents in Medicinal Chemistry Fibroblast Growth Factors, Fibroblast Growth Factor Receptors, Diseases, and Drugs
Recent Patents on Cardiovascular Drug Discovery Critical Parameters for Genome Editing Using Zinc Finger Nucleases
Mini-Reviews in Medicinal Chemistry The Metabolic Treatment of Patients with Coronary Artery Disease: Effects on Quality of Life and Effort Angina
Current Pharmaceutical Design Abdominal Aortic Aneurysm: What About Screening?
Current Pharmaceutical Design Cytochrome P450 in Neurological Disease
Current Drug Metabolism Developments in Non-Surgical Therapies for Abdominal Aortic Aneurysm
Current Vascular Pharmacology Oxidative Stress Modulation Through Habitual Physical Activity
Current Pharmaceutical Design